Structure

Physi-Chem Properties

Molecular Weight:  442.38
Volume:  505.518
LogP:  7.286
LogD:  5.487
LogS:  -6.075
# Rotatable Bonds:  5
TPSA:  37.3
# H-Bond Aceptor:  2
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  2

MedChem Properties

QED Drug-Likeness Score:  0.445
Synthetic Accessibility Score:  4.829
Fsp3:  0.9
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.737
MDCK Permeability:  1.0874752661038656e-05
Pgp-inhibitor:  0.917
Pgp-substrate:  0.003
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.982
30% Bioavailability (F30%):  0.933

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.782
Plasma Protein Binding (PPB):  98.0376205444336%
Volume Distribution (VD):  1.167
Pgp-substrate:  1.355882167816162%

ADMET: Metabolism

CYP1A2-inhibitor:  0.067
CYP1A2-substrate:  0.604
CYP2C19-inhibitor:  0.314
CYP2C19-substrate:  0.949
CYP2C9-inhibitor:  0.357
CYP2C9-substrate:  0.67
CYP2D6-inhibitor:  0.042
CYP2D6-substrate:  0.053
CYP3A4-inhibitor:  0.806
CYP3A4-substrate:  0.842

ADMET: Excretion

Clearance (CL):  7.081
Half-life (T1/2):  0.093

ADMET: Toxicity

hERG Blockers:  0.144
Human Hepatotoxicity (H-HT):  0.463
Drug-inuced Liver Injury (DILI):  0.65
AMES Toxicity:  0.012
Rat Oral Acute Toxicity:  0.903
Maximum Recommended Daily Dose:  0.868
Skin Sensitization:  0.902
Carcinogencity:  0.449
Eye Corrosion:  0.804
Eye Irritation:  0.418
Respiratory Toxicity:  0.979

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC53911

Natural Product ID:  NPC53911
Common Name*:   Cornusalterin K
IUPAC Name:   (1R,8R,9S,10R,13S,14R,17S)-1-hydroxy-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylheptan-2-yl]-1,2,7,8,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one
Synonyms:   Cornusalterin K
Standard InCHIKey:  FEAAYJYTVFABGY-UHNHVWPPSA-N
Standard InCHI:  InChI=1S/C30H50O2/c1-19(2)10-9-11-20(3)21-14-16-29(7)22-12-13-24-27(4,5)25(31)18-26(32)30(24,8)23(22)15-17-28(21,29)6/h13,19-23,26,32H,9-12,14-18H2,1-8H3/t20-,21-,22+,23-,26+,28-,29+,30+/m0/s1
SMILES:  CC(C)CCC[C@H](C)[C@@H]1CC[C@]2(C)[C@@H]3CC=C4C(C)(C)C(=O)C[C@H]([C@]4(C)[C@H]3CC[C@@]12C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1668104
PubChem CID:   50994389
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19594 Cornus walteri Species Cornaceae Eukaryota n.a. stem n.a. PMID[21182258]
NPO19594 Cornus walteri Species Cornaceae Eukaryota n.a. n.a. n.a. PMID[21182258]
NPO19594 Cornus walteri Species Cornaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens IC50 = 11680.0 nM PMID[449365]
NPT146 Cell Line SK-OV-3 Homo sapiens IC50 = 12830.0 nM PMID[449365]
NPT147 Cell Line SK-MEL-2 Homo sapiens IC50 = 12360.0 nM PMID[449365]
NPT574 Cell Line XF498 Homo sapiens IC50 = 12020.0 nM PMID[449365]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC53911 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9294 High Similarity NPC328313
0.9277 High Similarity NPC221758
0.9277 High Similarity NPC59453
0.9176 High Similarity NPC475740
0.9157 High Similarity NPC278648
0.9157 High Similarity NPC476082
0.907 High Similarity NPC328539
0.9059 High Similarity NPC474778
0.9059 High Similarity NPC474733
0.9059 High Similarity NPC145879
0.9059 High Similarity NPC474732
0.9059 High Similarity NPC31564
0.9059 High Similarity NPC51014
0.9036 High Similarity NPC151519
0.8966 High Similarity NPC474245
0.8966 High Similarity NPC32830
0.8966 High Similarity NPC186688
0.8966 High Similarity NPC86319
0.8966 High Similarity NPC1015
0.8966 High Similarity NPC31985
0.8966 High Similarity NPC275740
0.8953 High Similarity NPC472481
0.8953 High Similarity NPC472484
0.8953 High Similarity NPC472482
0.8953 High Similarity NPC58063
0.8941 High Similarity NPC202868
0.8941 High Similarity NPC469948
0.8913 High Similarity NPC110149
0.8876 High Similarity NPC477520
0.8864 High Similarity NPC48010
0.8851 High Similarity NPC143767
0.8851 High Similarity NPC131470
0.8851 High Similarity NPC471722
0.8851 High Similarity NPC471724
0.8837 High Similarity NPC20688
0.8837 High Similarity NPC155011
0.8824 High Similarity NPC85774
0.8824 High Similarity NPC82902
0.8824 High Similarity NPC214043
0.8764 High Similarity NPC185936
0.8764 High Similarity NPC168027
0.875 High Similarity NPC26959
0.875 High Similarity NPC268406
0.875 High Similarity NPC69627
0.875 High Similarity NPC76879
0.8736 High Similarity NPC96496
0.8736 High Similarity NPC474684
0.8736 High Similarity NPC298904
0.8736 High Similarity NPC57469
0.8736 High Similarity NPC142361
0.8721 High Similarity NPC470574
0.8721 High Similarity NPC471224
0.8721 High Similarity NPC474218
0.8696 High Similarity NPC190554
0.869 High Similarity NPC14151
0.8681 High Similarity NPC472485
0.8667 High Similarity NPC69454
0.8652 High Similarity NPC183283
0.8636 High Similarity NPC472483
0.8636 High Similarity NPC193360
0.8621 High Similarity NPC94755
0.8621 High Similarity NPC222613
0.8621 High Similarity NPC475022
0.8621 High Similarity NPC72133
0.8621 High Similarity NPC118648
0.8621 High Similarity NPC469994
0.8621 High Similarity NPC470955
0.8605 High Similarity NPC472265
0.8605 High Similarity NPC472480
0.8605 High Similarity NPC473246
0.8571 High Similarity NPC164999
0.8571 High Similarity NPC166906
0.8571 High Similarity NPC245972
0.8571 High Similarity NPC196485
0.8556 High Similarity NPC63748
0.8556 High Similarity NPC272746
0.8539 High Similarity NPC472477
0.8539 High Similarity NPC472970
0.8539 High Similarity NPC309603
0.8539 High Similarity NPC474704
0.8539 High Similarity NPC477943
0.8539 High Similarity NPC473999
0.8539 High Similarity NPC119416
0.8539 High Similarity NPC472971
0.8539 High Similarity NPC472475
0.8539 High Similarity NPC475921
0.8523 High Similarity NPC90652
0.8523 High Similarity NPC317590
0.8523 High Similarity NPC159046
0.8523 High Similarity NPC233836
0.8523 High Similarity NPC187376
0.8511 High Similarity NPC83709
0.8511 High Similarity NPC15390
0.8506 High Similarity NPC197823
0.8506 High Similarity NPC474083
0.8478 Intermediate Similarity NPC317586
0.8478 Intermediate Similarity NPC259286
0.8478 Intermediate Similarity NPC473170
0.8478 Intermediate Similarity NPC470016
0.8478 Intermediate Similarity NPC469599
0.8462 Intermediate Similarity NPC475255
0.8462 Intermediate Similarity NPC472930
0.8462 Intermediate Similarity NPC12722
0.8462 Intermediate Similarity NPC477855
0.8462 Intermediate Similarity NPC474807
0.8444 Intermediate Similarity NPC85173
0.8444 Intermediate Similarity NPC191684
0.8444 Intermediate Similarity NPC126993
0.8427 Intermediate Similarity NPC474677
0.8427 Intermediate Similarity NPC470417
0.8427 Intermediate Similarity NPC242864
0.8409 Intermediate Similarity NPC327115
0.8409 Intermediate Similarity NPC473168
0.8409 Intermediate Similarity NPC55309
0.8409 Intermediate Similarity NPC89077
0.8409 Intermediate Similarity NPC472491
0.8409 Intermediate Similarity NPC472494
0.8409 Intermediate Similarity NPC28252
0.8404 Intermediate Similarity NPC114274
0.8391 Intermediate Similarity NPC180834
0.8391 Intermediate Similarity NPC329043
0.8391 Intermediate Similarity NPC237712
0.8391 Intermediate Similarity NPC33913
0.8391 Intermediate Similarity NPC321187
0.8391 Intermediate Similarity NPC161423
0.8391 Intermediate Similarity NPC58841
0.8391 Intermediate Similarity NPC227064
0.8387 Intermediate Similarity NPC192428
0.8387 Intermediate Similarity NPC471463
0.8387 Intermediate Similarity NPC328162
0.8387 Intermediate Similarity NPC249954
0.8387 Intermediate Similarity NPC305483
0.8387 Intermediate Similarity NPC96859
0.8387 Intermediate Similarity NPC173272
0.8372 Intermediate Similarity NPC110780
0.8372 Intermediate Similarity NPC48362
0.837 Intermediate Similarity NPC474529
0.837 Intermediate Similarity NPC111015
0.837 Intermediate Similarity NPC292793
0.8353 Intermediate Similarity NPC2482
0.8353 Intermediate Similarity NPC472478
0.8352 Intermediate Similarity NPC473998
0.8352 Intermediate Similarity NPC131872
0.8352 Intermediate Similarity NPC189520
0.8352 Intermediate Similarity NPC212301
0.8352 Intermediate Similarity NPC86266
0.8352 Intermediate Similarity NPC110657
0.8352 Intermediate Similarity NPC475806
0.8333 Intermediate Similarity NPC84271
0.8333 Intermediate Similarity NPC102414
0.8333 Intermediate Similarity NPC122116
0.8333 Intermediate Similarity NPC185530
0.8333 Intermediate Similarity NPC128496
0.8333 Intermediate Similarity NPC77168
0.8333 Intermediate Similarity NPC474570
0.8333 Intermediate Similarity NPC82635
0.8333 Intermediate Similarity NPC2983
0.8316 Intermediate Similarity NPC477521
0.8315 Intermediate Similarity NPC4643
0.8315 Intermediate Similarity NPC93778
0.8315 Intermediate Similarity NPC141292
0.8315 Intermediate Similarity NPC73064
0.8315 Intermediate Similarity NPC138756
0.8313 Intermediate Similarity NPC240604
0.8313 Intermediate Similarity NPC321016
0.8313 Intermediate Similarity NPC107059
0.8313 Intermediate Similarity NPC300324
0.8313 Intermediate Similarity NPC321381
0.8298 Intermediate Similarity NPC18509
0.8298 Intermediate Similarity NPC108078
0.8295 Intermediate Similarity NPC133954
0.828 Intermediate Similarity NPC271195
0.828 Intermediate Similarity NPC472932
0.828 Intermediate Similarity NPC173875
0.828 Intermediate Similarity NPC200702
0.828 Intermediate Similarity NPC174948
0.828 Intermediate Similarity NPC127063
0.828 Intermediate Similarity NPC48330
0.828 Intermediate Similarity NPC318282
0.828 Intermediate Similarity NPC469995
0.8276 Intermediate Similarity NPC475726
0.8276 Intermediate Similarity NPC471036
0.8276 Intermediate Similarity NPC291320
0.8276 Intermediate Similarity NPC472743
0.8261 Intermediate Similarity NPC170220
0.8261 Intermediate Similarity NPC470224
0.8261 Intermediate Similarity NPC474736
0.8261 Intermediate Similarity NPC141497
0.8261 Intermediate Similarity NPC470375
0.8261 Intermediate Similarity NPC107674
0.8261 Intermediate Similarity NPC206810
0.8261 Intermediate Similarity NPC470376
0.8256 Intermediate Similarity NPC147066
0.8247 Intermediate Similarity NPC312900
0.8247 Intermediate Similarity NPC26478
0.8247 Intermediate Similarity NPC191892
0.8242 Intermediate Similarity NPC180849
0.8242 Intermediate Similarity NPC80401
0.8242 Intermediate Similarity NPC69622
0.8242 Intermediate Similarity NPC472476

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC53911 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9277 High Similarity NPD4786 Approved
0.9186 High Similarity NPD5328 Approved
0.9036 High Similarity NPD3667 Approved
0.8977 High Similarity NPD6079 Approved
0.8621 High Similarity NPD3618 Phase 1
0.8391 Intermediate Similarity NPD3133 Approved
0.8391 Intermediate Similarity NPD3665 Phase 1
0.8391 Intermediate Similarity NPD3666 Approved
0.8387 Intermediate Similarity NPD5222 Approved
0.8387 Intermediate Similarity NPD5221 Approved
0.8387 Intermediate Similarity NPD4697 Phase 3
0.8387 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.8298 Intermediate Similarity NPD4755 Approved
0.8298 Intermediate Similarity NPD5173 Approved
0.8261 Intermediate Similarity NPD6399 Phase 3
0.8261 Intermediate Similarity NPD4202 Approved
0.8193 Intermediate Similarity NPD6942 Approved
0.8193 Intermediate Similarity NPD7339 Approved
0.8182 Intermediate Similarity NPD3668 Phase 3
0.8125 Intermediate Similarity NPD4700 Approved
0.8125 Intermediate Similarity NPD5285 Approved
0.8125 Intermediate Similarity NPD4696 Approved
0.8125 Intermediate Similarity NPD5286 Approved
0.8041 Intermediate Similarity NPD5223 Approved
0.8 Intermediate Similarity NPD5279 Phase 3
0.8 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7959 Intermediate Similarity NPD5224 Approved
0.7959 Intermediate Similarity NPD4633 Approved
0.7959 Intermediate Similarity NPD5226 Approved
0.7959 Intermediate Similarity NPD5225 Approved
0.7959 Intermediate Similarity NPD5211 Phase 2
0.7955 Intermediate Similarity NPD4223 Phase 3
0.7955 Intermediate Similarity NPD4221 Approved
0.7935 Intermediate Similarity NPD4753 Phase 2
0.79 Intermediate Similarity NPD5739 Approved
0.79 Intermediate Similarity NPD7128 Approved
0.79 Intermediate Similarity NPD6675 Approved
0.79 Intermediate Similarity NPD6402 Approved
0.7889 Intermediate Similarity NPD5329 Approved
0.7889 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7882 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7879 Intermediate Similarity NPD5174 Approved
0.7879 Intermediate Similarity NPD5175 Approved
0.7879 Intermediate Similarity NPD4754 Approved
0.78 Intermediate Similarity NPD5141 Approved
0.7778 Intermediate Similarity NPD4197 Approved
0.7767 Intermediate Similarity NPD4634 Approved
0.7766 Intermediate Similarity NPD7515 Phase 2
0.7745 Intermediate Similarity NPD7320 Approved
0.7745 Intermediate Similarity NPD6881 Approved
0.7745 Intermediate Similarity NPD6899 Approved
0.7727 Intermediate Similarity NPD7525 Registered
0.7723 Intermediate Similarity NPD4768 Approved
0.7723 Intermediate Similarity NPD4767 Approved
0.7701 Intermediate Similarity NPD3617 Approved
0.767 Intermediate Similarity NPD6373 Approved
0.767 Intermediate Similarity NPD6372 Approved
0.7667 Intermediate Similarity NPD4788 Approved
0.7647 Intermediate Similarity NPD5697 Approved
0.7647 Intermediate Similarity NPD5701 Approved
0.7619 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7609 Intermediate Similarity NPD4138 Approved
0.7609 Intermediate Similarity NPD6409 Approved
0.7609 Intermediate Similarity NPD4689 Approved
0.7609 Intermediate Similarity NPD4688 Approved
0.7609 Intermediate Similarity NPD5330 Approved
0.7609 Intermediate Similarity NPD4693 Phase 3
0.7609 Intermediate Similarity NPD4690 Approved
0.7609 Intermediate Similarity NPD7521 Approved
0.7609 Intermediate Similarity NPD7334 Approved
0.7609 Intermediate Similarity NPD5205 Approved
0.7609 Intermediate Similarity NPD6684 Approved
0.7609 Intermediate Similarity NPD7146 Approved
0.7596 Intermediate Similarity NPD7290 Approved
0.7596 Intermediate Similarity NPD7102 Approved
0.7596 Intermediate Similarity NPD6883 Approved
0.7573 Intermediate Similarity NPD6011 Approved
0.7573 Intermediate Similarity NPD5168 Approved
0.7573 Intermediate Similarity NPD4729 Approved
0.7573 Intermediate Similarity NPD5128 Approved
0.7573 Intermediate Similarity NPD4730 Approved
0.7558 Intermediate Similarity NPD3703 Phase 2
0.7551 Intermediate Similarity NPD6083 Phase 2
0.7551 Intermediate Similarity NPD6084 Phase 2
0.7526 Intermediate Similarity NPD5210 Approved
0.7526 Intermediate Similarity NPD4629 Approved
0.7524 Intermediate Similarity NPD8130 Phase 1
0.7524 Intermediate Similarity NPD6617 Approved
0.7524 Intermediate Similarity NPD6650 Approved
0.7524 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7524 Intermediate Similarity NPD6869 Approved
0.7524 Intermediate Similarity NPD6649 Approved
0.7524 Intermediate Similarity NPD6847 Approved
0.75 Intermediate Similarity NPD6013 Approved
0.75 Intermediate Similarity NPD6012 Approved
0.75 Intermediate Similarity NPD6014 Approved
0.7453 Intermediate Similarity NPD8297 Approved
0.7453 Intermediate Similarity NPD6882 Approved
0.7447 Intermediate Similarity NPD6903 Approved
0.7447 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7447 Intermediate Similarity NPD5737 Approved
0.7447 Intermediate Similarity NPD6672 Approved
0.7444 Intermediate Similarity NPD4692 Approved
0.7444 Intermediate Similarity NPD4139 Approved
0.7442 Intermediate Similarity NPD6926 Approved
0.7442 Intermediate Similarity NPD6924 Approved
0.7429 Intermediate Similarity NPD5250 Approved
0.7429 Intermediate Similarity NPD5169 Approved
0.7429 Intermediate Similarity NPD5248 Approved
0.7429 Intermediate Similarity NPD5247 Approved
0.7429 Intermediate Similarity NPD5249 Phase 3
0.7429 Intermediate Similarity NPD5135 Approved
0.7429 Intermediate Similarity NPD5251 Approved
0.7429 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD7748 Approved
0.7419 Intermediate Similarity NPD5690 Phase 2
0.7419 Intermediate Similarity NPD5280 Approved
0.7419 Intermediate Similarity NPD4694 Approved
0.7396 Intermediate Similarity NPD6411 Approved
0.7381 Intermediate Similarity NPD3699 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD3700 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD5127 Approved
0.7358 Intermediate Similarity NPD5217 Approved
0.7358 Intermediate Similarity NPD5216 Approved
0.7358 Intermediate Similarity NPD5215 Approved
0.7339 Intermediate Similarity NPD7115 Discovery
0.7333 Intermediate Similarity NPD4695 Discontinued
0.7317 Intermediate Similarity NPD3171 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD6054 Approved
0.7297 Intermediate Similarity NPD6059 Approved
0.7294 Intermediate Similarity NPD4747 Approved
0.7294 Intermediate Similarity NPD4789 Approved
0.7294 Intermediate Similarity NPD4245 Approved
0.7294 Intermediate Similarity NPD4244 Approved
0.7273 Intermediate Similarity NPD6117 Approved
0.7273 Intermediate Similarity NPD6933 Approved
0.7248 Intermediate Similarity NPD6868 Approved
0.7241 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD4785 Approved
0.7241 Intermediate Similarity NPD4784 Approved
0.7234 Intermediate Similarity NPD6098 Approved
0.7222 Intermediate Similarity NPD7645 Phase 2
0.7222 Intermediate Similarity NPD4632 Approved
0.7222 Intermediate Similarity NPD4195 Approved
0.7216 Intermediate Similarity NPD8034 Phase 2
0.7216 Intermediate Similarity NPD8035 Phase 2
0.7212 Intermediate Similarity NPD6008 Approved
0.7209 Intermediate Similarity NPD4243 Approved
0.7209 Intermediate Similarity NPD7152 Approved
0.7209 Intermediate Similarity NPD7150 Approved
0.7209 Intermediate Similarity NPD7151 Approved
0.72 Intermediate Similarity NPD7902 Approved
0.7191 Intermediate Similarity NPD6116 Phase 1
0.7188 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD6101 Approved
0.7176 Intermediate Similarity NPD3698 Phase 2
0.7176 Intermediate Similarity NPD6922 Approved
0.7176 Intermediate Similarity NPD4137 Phase 3
0.7176 Intermediate Similarity NPD6923 Approved
0.7172 Intermediate Similarity NPD5695 Phase 3
0.7168 Intermediate Similarity NPD6370 Approved
0.7158 Intermediate Similarity NPD4751 Clinical (unspecified phase)
0.7156 Intermediate Similarity NPD5167 Approved
0.7143 Intermediate Similarity NPD6319 Approved
0.7143 Intermediate Similarity NPD4748 Discontinued
0.7129 Intermediate Similarity NPD7638 Approved
0.7129 Intermediate Similarity NPD5696 Approved
0.7117 Intermediate Similarity NPD6335 Approved
0.7111 Intermediate Similarity NPD6114 Approved
0.7111 Intermediate Similarity NPD6697 Approved
0.7111 Intermediate Similarity NPD6118 Approved
0.7111 Intermediate Similarity NPD6115 Approved
0.7093 Intermediate Similarity NPD7144 Approved
0.7093 Intermediate Similarity NPD7143 Approved
0.7093 Intermediate Similarity NPD4691 Approved
0.7091 Intermediate Similarity NPD6274 Approved
0.708 Intermediate Similarity NPD6016 Approved
0.708 Intermediate Similarity NPD6015 Approved
0.7059 Intermediate Similarity NPD5360 Phase 3
0.7059 Intermediate Similarity NPD3621 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD7640 Approved
0.7059 Intermediate Similarity NPD5361 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD7639 Approved
0.7054 Intermediate Similarity NPD7100 Approved
0.7054 Intermediate Similarity NPD7101 Approved
0.7053 Intermediate Similarity NPD4623 Approved
0.7053 Intermediate Similarity NPD4519 Discontinued
0.7045 Intermediate Similarity NPD5733 Approved
0.7043 Intermediate Similarity NPD7492 Approved
0.7041 Intermediate Similarity NPD5284 Approved
0.7041 Intermediate Similarity NPD5281 Approved
0.7033 Intermediate Similarity NPD6929 Approved
0.7027 Intermediate Similarity NPD6317 Approved
0.7027 Intermediate Similarity NPD6009 Approved
0.7018 Intermediate Similarity NPD5988 Approved
0.701 Intermediate Similarity NPD6673 Approved
0.701 Intermediate Similarity NPD6904 Approved
0.701 Intermediate Similarity NPD6080 Approved
0.701 Intermediate Similarity NPD7285 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data